Erin Doyle, | |
816 S Interocean Ave, Holyoke, CO 80734-2120 | |
(970) 854-5180 | |
Not Available |
Full Name | Erin Doyle |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 816 S Interocean Ave, Holyoke, Colorado |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1780170589 | NPI | - | NPPES |
Provider Name | Empowerme Rehabilitation Colorado, Llc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1063176493 PECOS PAC ID: 0446641179 Enrollment ID: O20220106001466 |
News Archive
Women giving birth after undergoing fertility treatment face an increased risk of depression compared to women ending up not having a child following fertility treatment, according to new research from the University of Copenhagen. According to the researchers, this has key implications for fertility treatment in future.
Comprehensive analyses of pooled data from three randomized, double-blind, placebo-controlled Phase II/III trials showing the efficacy and tolerability of VimpatĀ® (lacosamide) C-V for patients with partial-onset seizures, regardless of the type of concomitant AED used, have been published in the drug evaluation journal, CNS Drugs.
Alcon, the global leader in eye care and a division of Novartis, is expanding its extensive, global support of eye care professionals through the unveiling of the Alcon Experience Academy.
The drug perampanel (trade name Fycompa) has been approved since July 2012 as adjunctive ("add-on") therapy for adults and children aged 12 years and older with epileptic fits (seizures).
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Erin Doyle, 8657 Litzsinger Rd, Saint Louis, MO 63144-2422 Ph: (314) 359-3983 | Erin Doyle, 816 S Interocean Ave, Holyoke, CO 80734-2120 Ph: (970) 854-5180 |
News Archive
Women giving birth after undergoing fertility treatment face an increased risk of depression compared to women ending up not having a child following fertility treatment, according to new research from the University of Copenhagen. According to the researchers, this has key implications for fertility treatment in future.
Comprehensive analyses of pooled data from three randomized, double-blind, placebo-controlled Phase II/III trials showing the efficacy and tolerability of VimpatĀ® (lacosamide) C-V for patients with partial-onset seizures, regardless of the type of concomitant AED used, have been published in the drug evaluation journal, CNS Drugs.
Alcon, the global leader in eye care and a division of Novartis, is expanding its extensive, global support of eye care professionals through the unveiling of the Alcon Experience Academy.
The drug perampanel (trade name Fycompa) has been approved since July 2012 as adjunctive ("add-on") therapy for adults and children aged 12 years and older with epileptic fits (seizures).
› Verified 7 days ago
Valerie Mcculley, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 415 S Worley Ave, Holyoke, CO 80734 Phone: 308-293-2854 |